Back to top
more

VAREX IMAGING (VREX)

(Delayed Data from NSDQ)

$9.48 USD

9.48
1,979,950

+1.67 (21.38%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $9.46 -0.02 (-0.21%) 4:48 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value A Growth D Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 37% (153 out of 244)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Kinjel Shah headshot

Add These 5 Low Price-to-Book Stocks to Your Portfolio in May

by Kinjel Shah

The P/B ratio helps to identify low-priced stocks that have high growth prospects. Deutsche Bank (DB), General Motors (GM), Unum Group (UNM), PVH Corp. (PVH) and Varex Imaging Corporation (VREX) are some such stocks.

Zacks Equity Research

Here's Why VAREX IMAGING (VREX) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does VAREX IMAGING (VREX) have what it takes to be a top stock pick for momentum investors? Let's find out.

Zacks Equity Research

VAREX IMAGING (VREX) Upgraded to Strong Buy: Here's What You Should Know

by Zacks Equity Research

VAREX IMAGING (VREX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).

Zacks Equity Research

Best Momentum Stocks to Buy for May 5th

by Zacks Equity Research

VREX, LGND and FLS made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 5, 2023.

Zacks Equity Research

New Strong Buy Stocks for May 5th

by Zacks Equity Research

VREX, LGND, RNGR, SIGA and KMT have been added to the Zacks Rank #1 (Strong Buy) List on May 5, 2023.

Zacks Equity Research

Surging Earnings Estimates Signal Upside for VAREX IMAGING (VREX) Stock

by Zacks Equity Research

VAREX IMAGING (VREX) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Zacks Equity Research

VREX or HAE: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

VREX vs. HAE: Which Stock Is the Better Value Option?

Zacks Equity Research

VAREX IMAGING (VREX) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 52.94% and 6.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

All You Need to Know About VAREX IMAGING (VREX) Rating Upgrade to Buy

by Zacks Equity Research

VAREX IMAGING (VREX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

VREX or BSX: Which Is the Better Value Stock Right Now?

by Zacks Equity Research

VREX vs. BSX: Which Stock Is the Better Value Option?

Zacks Equity Research

Is Smith & Nephew SNATS (SNN) Stock Undervalued Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

VAREX IMAGING (VREX) Misses Q1 Earnings Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of -27.27% and 0.12%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Are Investors Undervaluing VAREX IMAGING (VREX) Right Now?

by Zacks Equity Research

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks Equity Research

VREX vs. LMAT: Which Stock Is the Better Value Option?

by Zacks Equity Research

VREX vs. LMAT: Which Stock Is the Better Value Option?

Zacks Equity Research

Implied Volatility Surging for Varex Imaging (VREX) Stock Options

by Zacks Equity Research

Investors need to pay close attention to Varex Imaging (VREX) stock based on the movements in the options market lately.

Zacks Equity Research

VAREX IMAGING (VREX) Surpasses Q4 Earnings and Revenue Estimates

by Zacks Equity Research

VAREX IMAGING (VREX) delivered earnings and revenue surprises of 52.38% and 3.28%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Biora Therapeutics, Inc. (BIOR) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Biora Therapeutics, Inc. (BIOR) delivered earnings and revenue surprises of -33.33% and 20%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

BellRing Brands (BRBR) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

BellRing Brands (BRBR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

TG Therapeutics (TGTX) Reports Q3 Loss, Lags Revenue Estimates

by Zacks Equity Research

TG Therapeutics (TGTX) delivered earnings and revenue surprises of 21.21% and 97.21%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Analysts Estimate VAREX IMAGING (VREX) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

VAREX IMAGING (VREX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Equity Research

NanoString Technologies (NSTG) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

NanoString (NSTG) delivered earnings and revenue surprises of -71.74% and 16.66%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Zacks Equity Research

Zimmer Biomet (ZBH) Americas Business Slows Down Amid Pandemic

by Zacks Equity Research

Zimmer Biomet (ZBH) continues to face COVID-induced challenges and market pressure.

Zacks Equity Research

Here's Why You Should Hold on to Alcon (ALC) Stock for Now

by Zacks Equity Research

Investors are optimistic about Alcon's (ALC) better-than-expected third-quarter results and robust performance by the Vision Care arm.

Zacks Equity Research

Avantor (AVTR) to Improve Biopharma Supply Chain With New Site

by Zacks Equity Research

Avantor's (AVTR) new logistics hub in Westminster is intended to support growth of single-use businesses.

Zacks Equity Research

Here's Why You Should Hold on to NEOGEN (NEOG) Stock for Now

by Zacks Equity Research

Investors are optimistic about NEOGEN (NEOG) given robust sales growth in the Food Safety business and impressive international performance.